Statin and Aspirin Use and the Risk of Mood Disorders among Men

International Journal of Neuropsychopharmacology

Volumn 19, Issue 6, 2016, Pages 1-4

  Williams, Lana J ^a   Pasco, Julie A ^a,b   Mohebbi, Mohammadreza ^a   Jacka, Felice N ^a,b,c,d   Stuart, Amanda L ^a   Venugopal, Kamalesh ^a,e   O'Neil, Adrienne ^a,f,g   Berk, Michael ^a,b,h,i  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d BLACK DOG INSTITUTE   (Australia)

^e South Australia Health Medical Research Institute   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

ⁱ THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

Aspirin; Cytokines; Depression; Epidemiology; Immune system; Inflammation; Mood disorder; Prevention; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROL; CONTROLLED STUDY; DRUG USE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OSTEOPOROSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK; SEMI STRUCTURED INTERVIEW;

EID: 84979680796     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyw008     Document Type: Article

References (10)

1. Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M (2013a) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200.
2. Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O'Neil A, Davey CG, Sanna L, Maes M (2013b) Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med 11:74.
3. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46-56.
4. DellaGioia N, Hannestad J (2010) A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev 34:130-143.
5. Dinarello CA (2010) Anti-inflammatory agents: present and future. Cell 140:935-950.
6. Hyyppa MT, Kronholm E, Virtanen A, Leino A, Jula A (2003) Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology 28:181-194.
7. Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA, Anderson G, Jacka FN, Maes M (2014) Oxidative and nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46-62.
8. O'Neil A, Sanna L, Redlich C, Sanderson K, Jacka F, Williams LJ, Pasco JA, Berk M (2012) The impact of statins on psychological wellbeing: a systematic review and meta-analysis. BMC Med 10:154.
9. Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M (2010) Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 79:323-325.
10. Pasco JA, Nicholson GC, Kotowicz MA (2012) Cohort profile: Geelong Osteoporosis Study. Int J Epidemiol 41:1565-1575.